Acomplia Treatment
Acomplia is a new drug thas has shown great promise in trials
for the treatment of obesity and related metabolic risk factors.
Rimonabant is already on the market in Europe, being sold under
the trade name Acomplia, and is awaiting approval in the United
States.
Acomplia diet treatment helps weight loss
Acomplia active ingredient is Rimonabant. Acomplia (Rimonabant),
developed by Sanofi-Aventis, indicated for the treatment of obesity.
It also has potential as a treatment for smoking cessation because
the endocannabinoid system is involved in the body's response
to tobacco dependence
Acomplia treatment is just not consumption of a diet pill. It
requires to be combined with a low calorie diet and regular workout
regime to attain effectual weight loss results. Acomplia decreases
your normal appetite, and as a result you would eat in smaller
portions. Smaller portions means a decreased food consumption,
and you thereby lose weight. Patients should take one 20mg tablet
every morning with breakfast.
|
We
compare buying conditions of all respectable suppliers that
offer Rimonabant online
News
and Articles:
